OakChart

Lifeward Ltd

LFWDHealthcare·Medical Devices·USA·Nano·NASD·Nov 11 • 3:59 PM ET

5.76-0.08 (-1.45%)
2026-11-11 22:30 CET
Market cap
16.55 USD m
Revenue, TTM
21.82 USD m
Net income, TTM
-30.83 USD m
Free cash flow, TTM
-17.10 USD m
EPS diluted, TTM
-16.79
P/E
-
Compare

Price

LFWD against its 20, 50 and 200-day averages
2050200miss
5.006.007.008.009.0063K127KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LFWDclose 5.7620-day 5.8750-day 6.42200-day 6.875.7652w high

40.1% under the 52-week high of 9.61 on 6 Jul 2026. 52-week low 4.14 on 24 Feb 2026. Last 15 sessions, 15.2% high to low

Volume 0.55× normal · the line is the 50-bar volume average

Profile

LFWD
52-week range, 30% of the way up
4.149.61

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Hudson, MA.

Employees81
IPOSep 12, 2014
Beta0.56
ATR, 14d0.32
Rel volume0.55
Short float5.75%
Insider own46.22%
Inst own1.15%

Snapshot

6 groups

Valuation

Index-
Market Cap16.31M
Enterprise Value17.93M
Income-30.83M
Sales21.82M
Book/sh4.32
Cash/sh3.34
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees81
IPOSep 12, 2014

Ratios

P/E-
Forward P/E-
PEG-
P/S0.75
P/B1.33
P/C1.73
P/FCF-
EV/EBITDA-
EV/Sales0.82
Quick Ratio1.77
Current Ratio2.33
Debt/Eq0.91
LT Debt/Eq0.85
Option/ShortNo / Yes

Earnings

EPS (ttm)-16.79
EPS next Y-1.35
EPS next Q-0.79
EPS this Y56.92%
EPS next Y76.32%
EPS next 5Y65.57%
EPS past 3/5Y13.32% 24.32%
Sales past 3/5Y58.72% 38.06%
EPS Y/Y TTM55.33%
Sales Y/Y TTM-10.68%
EPS Q/Q41.26%
Sales Q/Q15.71%
EarningsAug 14 BMO
EPS/Sales Surpr.-5.32% 1.41%

Ownership

Insider Own46.22%
Insider Trans0.00%
Inst Own1.15%
Inst Trans0.90%
ROA-99.81%
ROE-225.65%
ROIC-136.75%
Gross Margin24.48%
Oper. Margin-81.79%
Profit Margin-141.28%
SMA20-1.94%
SMA50-10.21%
SMA200-16.13%
Trades-

Technical

Shs Outstand2.83M
Shs Float1.52M
Short Float5.75%
Short Ratio8.10
Short Interest0.09M
52W High9.61 -40.06%
52W Low4.14 39.13%
Volatility4.45% 4.65%
ATR (14)0.32
RSI (14)43.42
Beta0.56
Rel Volume0.55
Avg Volume10.78K
Volume5,881

Performance

Perf Week-4.95%
Perf Month-5.58%
Perf Quarter-27.04%
Perf Half Y-13.12%
Perf YTD-16.75%
Perf Year-9.21%
Perf 3Y-90.20%
Perf 5Y-95.58%
Perf 10Y-99.90%
Recom1.00
Target Price20.00
Prev Close5.84
Price5.76
Change %-1.45%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
Feb 10, 2025InitiatedLLaidlawBuy$10+73.6%
Apr 03, 2017DowngradeBBarclaysEqual Weight → Underweight$2.50 → $1.50-74.0%
Dec 16, 2016InitiatedOOppenheimerOutperform
Jul 15, 2016InitiatedPPiper JaffrayOverweight$10+73.6%
May 22, 2015UpgradeCCanaccord GenuityHold → Buy$11 → $17+195.1%
May 08, 2015ReiteratedBBarclaysEqual Weight$20 → $13+125.7%
Oct 07, 2014InitiatedBBarclaysEqual Weight$28+386.1%

Peers

Mkt cap
TickerCompanyMkt cap
MYOMyomo Inc50.13M
TCMDTactile Systems Technology Inc607.74M
INGNInogen Inc149.51M
ECORElectroCore Inc71.13M
STIMNeuronetics Inc124.36M
ELMDElectromed Inc206.84M
VMDViemed Healthcare Inc346.53M
NXLNexalin Technology Inc1.83M
HSCSHeartSciences Inc11.40M
VVOSVivos Therapeutics Inc3.04M

Held by

AUM
TickerCompanyAUM
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B

News

latest 14 of 198
  • Lifeward's ReWalk Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed Study (GlobeNewswire)
  • Peer-Reviewed Study of Lifeward's ReWalk Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and Pain (GlobeNewswire)
  • Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy (GlobeNewswire) +6.02%
  • Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer (GlobeNewswire) -5.88%
  • Lifeward: Q2 Earnings Snapshot (Associated Press) -5.64%
  • Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth (GlobeNewswire)
  • Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside (GuruFocus.com)
  • Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026 (GlobeNewswire)
  • Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk Personal Exoskeleton (GlobeNewswire)
  • Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing (GlobeNewswire)
  • Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform (GlobeNewswire)
  • Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ... (GuruFocus.com)
  • Lifeward: Q1 Earnings Snapshot (Associated Press)
  • Lifeward Reports First Quarter 2026 Financial Results (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-14-1.460-1.386-4.1206.626.532
2026Q12026-05-15-3.130-1.180-6.7003.925.782
2025Q42026-03-18-2.850-0.960-3.5955.087.872
2025Q32025-11-14-2.280-2.400-2.3746.206.312
2025Q22025-08-14-3.720-3.420-7.0125.726.692
2025Q12025-05-15-5.280-3.960-5.5325.035.843
2024Q42025-03-07-20.760-6.520-20.8167.557.843
2024Q32024-11-12-4.200-3.780-4.2266.138.442
2024Q22024-08-15-6.000-6.600-5.9996.716.652
2024Q12024-05-15-8.760-8.400-8.7675.285.501
2023Q42024-02-27-10.920-9.240-7.8896.887.231
2023Q32023-11-14-10.920-9.240-10.5794.404.281
2023Q22023-08-11-6.720-5.880-6.5521.341.301
2023Q12023-05-11-5.880-6.720-6.0981.232.001
2022Q42023-02-23-7.560-5.880-7.2362.182.051
2022Q32022-11-07-7.560-5.040-7.3040.891.821

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-226.8-213.36-226.664.876.00
2020FY-68.880-69.720-69.1404.394.68
2021FY-22.680-20.160-22.3185.976.51
2022FY-26.040-25.200-26.3525.515.38
2023FY-31.080-31.920-31.13213.8514.20
2024FY-39.960-25.120-39.96025.6625.61
2025FY-13.230-10.680-17.16022.0324.98
2026FY--5.700--25.24
2027FY--1.350--41.82
2028FY--0.540--56.10
2029FY-0.260--72.36
2030FY-0.925--88.81

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-022007.246.018.47
2026Q3S2026-08-192017.246.018.47
2026Q3S2026-08-142008.556.0111.08
2026Q3S2026-08-052008.556.0111.08
2026Q3S2026-07-292018.556.0111.08
2026Q3S2026-05-252118.556.0111.08
2026Q3S2026-05-222118.556.0111.08
2026Q3S2026-05-152108.606.0111.20
2026Q3S2026-03-182008.545.8711.20
2026Q3S2025-11-1710011.1011.1011.10
2026Q3R2026-10-28100-1.11-1.11-1.11
2026Q3R2026-08-14101-1.11-1.11-1.11
2026Q3R2026-07-29100-0.99-0.99-0.99
2026Q3R2026-05-15101-0.99-0.99-0.99

Estimate history

EPS, annual-2562-1236.459-226.655-69.14-22.318-26.352-31.132-39.96-17.16-16.7881
Period201720182019202020212022202320242025TTM
EPS, quarterly-5.999-4.226-20.816-5.532-7.012-2.374-3.595-6.7-4.119
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual7.7536.5454.8734.3935.9665.51113.85425.66322.03421.82
Period201720182019202020212022202320242025TTM
Sales, quarterly6.7076.1287.5455.0345.7246.1955.0813.9236.623
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual0.0140.0330.0870.3020.7440.7150.7160.7341.5242.828
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.7190.7340.7340.8861.3051.4051.5242.7792.828
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue21.8222.0325.6613.855.515.974.394.876.54
Cost of Goods Sold Incl. D&A16.4813.6117.4510.103.613.062.202.153.72
Gross Profit5.348.438.223.751.912.902.192.732.83
Selling, General and Administrative Excl. Other23.1925.3227.7724.2021.0115.5614.1916.7722.04
Research and Development4.263.254.623.974.032.943.465.357.35
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-17.85-16.89-19.55-20.44-19.10-12.65-12.00-14.05-19.21
Interest Expense1.840.440.130.020.020.030.931.532.42
Unusual Expense4.902.789.793.170.000.000.000.000.00
Net Income Before Taxes-30.88-19.97-28.90-22.14-19.10-12.64-12.93-15.54-21.68
Income Taxes-0.05-0.060.04-0.010.470.090.050.01-0.01
Consolidated Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Net Income From Continuing Operations-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
EPS (Recurring)-9.80-15.48-30.49-28.01-26.35-22.32-69.14-226.65-1,236.47
EPS (Basic, Before Extraordinaries)-16.79-17.16-39.96-31.13-26.35-22.32-69.14-226.65-1,236.46
EPS (Diluted)-16.79-17.16-39.96-31.13-26.35-22.32-69.14-226.65-1,236.46
EBITDA-12.62-16.56-15.71-18.59-18.90-12.39-11.72-13.73-18.75
Non-Operating Income (Expense)-6.290.140.581.490.020.040.010.03-0.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.610.591.011.050.780.610.550.812.19
Price To Sales Ratio0.980.360.593.358.609.884.742.550.98
Gross Margin24.4838.2532.0127.0934.5748.6649.8355.9443.16
Operating Margin-81.79-76.66-76.19-147.55-346.62-212.12-273.25-288.28-293.57
Net Margin-141.28-90.38-112.78-159.76-355.09-213.48-295.38-319.13-331.17
Shares Outstanding2.831.520.730.720.720.740.300.090.03
Market Capitalization16.5516.5515.2446.6847.6776.8533.4415.8112.24

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue6.623.925.086.205.725.037.546.13
Cost of Goods Sold Incl. D&A3.915.083.993.493.212.915.704.41
Gross Profit2.71-1.161.092.712.512.121.841.72
Selling, General and Administrative Excl. Other6.864.286.215.856.296.977.284.89
Research and Development1.750.940.840.720.770.921.131.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.15-5.44-5.12-3.14-3.78-4.85-5.43-3.17
Interest Expense0.380.960.460.030.040.03-0.03
Unusual Expense0.004.900.000.002.780.009.790.00
Net Income Before Taxes-11.51-10.79-5.42-3.16-6.56-4.82-15.28-3.06
Income Taxes0.010.01-0.070.010.000.010.000.03
Consolidated Net Income-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
Net Income From Continuing Operations-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
Net Income-11.52-10.79-5.35-3.17-6.56-4.83-15.28-3.08
EPS (Recurring)-4.12-4.57-3.60-2.37-4.93-5.53-11.47-4.23
EPS (Basic, Before Extraordinaries)-4.12-6.70-3.60-2.37-7.01-5.53-20.82-4.23
EPS (Diluted)-4.12-6.70-3.60-2.37-7.01-5.53-20.82-4.23
EBITDA-4.08-0.43-5.05-3.06-3.69-4.76-4.47-2.21
Non-Operating Income (Expense)-6.970.510.160.010.040.06-0.050.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.210.140.130.140.180.170.180.23
Price To Sales Ratio0.980.510.470.470.300.700.591.14
Gross Margin40.90-29.5921.4143.7043.8742.1524.4428.07
Operating Margin-62.69-138.64-100.73-50.69-66.04-96.40-72.02-51.80
Net Margin-173.92-275.12-105.25-51.17-114.64-96.03-202.49-50.33
Shares Outstanding2.832.781.521.411.300.890.730.73
Market Capitalization16.5510.1310.5512.0010.1018.0715.2428.71

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2.416.9428.0867.9088.3420.3516.259.5514.57
Short Term Receivables6.146.003.121.040.580.680.790.761.10
Inventories5.736.725.793.102.993.783.372.614.28
Other Current Assets1.531.622.230.470.600.430.660.320.99
Total Current Assets15.8121.2939.2272.5192.5225.2521.0713.2420.94
Net Property, Plant & Equipment2.131.423.121.031.171.792.240.630.84
Total Investments and Advances0.170.360.710.660.710.700.740.800.86
Intangible Assets4.757.5420.06-----0.00
Other Assets0.04-0.120.070.040.350.330.320.300.23
Total Assets22.9030.4963.1974.2494.7528.0724.3714.9622.86
Short Term Debt Incl. Current Port. of LT Debt3.230.861.300.560.640.666.081.726.44
Accounts Payable5.595.025.071.951.382.272.702.331.81
Other Current Liabilities3.224.345.432.272.011.741.401.331.48
Total Current Liabilities12.0410.2211.794.784.044.6710.175.389.73
Long Term Debt1.160.020.610.330.420.922.846.968.91
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities1.291.394.280.960.910.700.580.670.52
Total Liabilities14.4911.6416.686.075.376.2913.5913.0219.16
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity8.4118.8546.5168.1789.3821.7710.781.953.71
Total Shareholders Equity8.4118.8546.5168.1789.3821.7710.781.953.71
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity8.4118.8546.5168.1789.3821.7710.781.953.71
Total Liabilities & Stockholders Equity22.9030.4963.1974.2494.7528.0724.3714.9622.86
Book Value Per Share5.5225.6864.9995.29120.1772.20123.7158.08259.46
Tangible Book Value Per Share2.4015.4136.9695.29120.1772.20123.7158.08259.46
Full-Time Employees8180108565149505865
Price to Book Ratio1.350.810.900.630.861.541.476.3017.91
Return on Assets-74.60-61.79-32.21-23.16-20.74-49.49-79.07-114.61-90.50
Return on Equity-146.12-88.56-38.60-24.84-22.92-79.72-244.42-766.99-413.09
Return on Invested Capital-208.15-153.37-46.97-28.57-14.18-57.17-114.16-243.27-195.89
Quick Ratio0.841.432.8314.5122.174.601.741.971.71
Current Ratio1.312.083.3315.1622.915.412.072.462.15

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-30.83-19.91-28.94-22.13-19.57-12.74-12.98-15.55-21.68
Depreciation5.230.333.841.850.200.270.280.320.46
Other Funds (Non Cash)8.422.618.360.961.070.830.361.113.59
Funds from Operations-16.74-16.53-16.74-19.33-17.98-11.67-12.38-14.18-17.73
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.33-0.30-4.97-1.340.090.20-0.21-0.642.96
Cash from Operating Activities-17.08-16.83-21.72-20.67-17.89-11.47-12.59-14.81-14.77
Capital Expenditures-0.02-0.020.00-0.08-0.03-0.05-0.07-0.02-0.01
Net Assets From Acquisitions0.000.000.00-18.070.000.000.000.00-
Sale of Fixed Assets and Businesses6.500.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-0.020.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities6.46-0.020.00-18.15-0.03-0.05-0.07-0.02-0.01
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.429.200.00-0.99-2.5079.5123.3023.2013.58
Repurchase of Common Pref Stock0.000.000.00-0.99-2.500.000.000.000.00
Sale of Common Pref Stock1.429.200.000.000.0079.5123.3023.2013.58
Proceedsfrom Stock Options1.429.200.000.000.0064.4519.070.0013.58
Issuance or Reduction of Debt, Net5.521.440.000.000.000.00-6.57-1.72-3.87
Change in Long Term Debt4.080.000.000.000.000.00-6.57-1.72-3.87
Issuance of Long Term Debt4.080.000.000.000.000.000.390.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00-6.96-1.72-3.87
Net Financing Active Other Cash Flow7.991.560.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities14.9312.200.00-0.99-2.5079.5116.7221.489.71
Exchange Rate Effect0.050.110.030.04-0.08----
Net Change in Cash4.37-4.53-21.68-39.76-20.5068.004.066.64-5.08
Free Cash Flow-17.10-16.84-21.72-20.75-17.92-11.52-12.66-14.84-14.79
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.440.000.000.32-0.03-0.04-0.06-0.11

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments9.4511.432.412.195.355.92
Short Term Receivables7.865.666.146.135.865.17
Inventories6.156.255.737.117.626.80
Other Current Assets2.482.211.531.921.871.93
Total Current Assets25.9525.5615.8117.3520.7119.82
Net Property, Plant & Equipment3.002.062.130.861.081.23
Total Investments and Advances0.000.000.170.000.000.36
Intangible Assets5.194.754.754.754.757.54
Other Assets0.871.040.040.200.23-0.14
Total Assets35.0033.4222.9023.1726.7828.81
Short Term Debt Incl. Current Port. of LT Debt0.740.423.230.150.300.57
Accounts Payable6.136.385.595.256.114.47
Other Current Liabilities4.283.833.223.653.954.03
Total Current Liabilities11.1610.6312.049.0510.369.07
Long Term Debt10.338.391.160.090.080.05
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities1.308.101.291.271.231.23
Total Liabilities22.7827.1314.4910.4111.6710.35
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity12.226.298.4112.7615.1118.46
Total Shareholders Equity12.226.298.4112.7615.1118.46
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity12.226.298.4112.7615.1118.46
Total Liabilities & Stockholders Equity35.0033.4222.9023.1726.7828.81
Book Value Per Share4.322.265.529.0811.5820.83
Tangible Book Value Per Share2.490.552.405.697.9412.32
Full-Time Employees--81---
Price to Book Ratio1.351.201.250.940.670.98
Return on Assets-99.81-83.16-74.60-86.58-76.54-65.46
Return on Equity-225.65-209.10-146.12-127.95-114.90-93.11
Return on Invested Capital-51.10-73.52-55.90-24.68-43.20-26.12
Quick Ratio1.771.820.841.131.261.43
Current Ratio2.332.401.311.922.002.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-11.52-10.79-5.35-3.17-6.56-4.83
Depreciation0.075.010.070.080.090.09
Other Funds (Non Cash)7.610.70-0.040.142.290.21
Funds from Operations-3.84-5.08-4.87-2.95-4.18-4.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.161.411.32-0.900.24-0.96
Cash from Operating Activities-6.00-3.67-3.56-3.84-3.94-5.49
Capital Expenditures-0.010.00-0.010.000.00-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.006.500.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-0.020.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.036.50-0.010.000.00-0.01
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.780.653.314.47
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.780.653.314.47
Proceedsfrom Stock Options0.000.000.780.653.314.47
Issuance or Reduction of Debt, Net4.080.001.440.000.000.00
Change in Long Term Debt4.080.000.000.000.000.00
Issuance of Long Term Debt4.080.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.006.421.560.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities4.086.423.780.653.314.47
Exchange Rate Effect0.010.000.010.030.060.01
Net Change in Cash-1.949.250.22-3.16-0.56-1.02
Free Cash Flow-6.01-3.67-3.57-3.84-3.94-5.50

Revenue breakdown

Lease Of Products2024: 2.56M 2025: 1.78M
Product2024: 19.92M 2025: 17.17M
Service And Warranty2024: 3.19M 2025: 3.09M
Asia Pacific2024: 825.00K 2025: 460.00K
Europe2024: 5.12M 2025: 2.91M
Germany2024: 4.42M 2025: 4.01M
Rest Of World2024: 867.00K 2025: 1.42M
United States2024: 14.43M 2025: 13.24M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.75%0.1M1.5M7.63K
2026-10-155.90%0.1M1.5M5.82K
2026-09-306.35%0.1M1.5M9.24K
2026-09-156.99%0.1M1.5M9.75K
2026-08-317.48%0.1M1.5M10.15K
2026-08-148.03%0.1M1.5M11.49K
2026-07-318.12%0.1M1.5M11.53K
2026-07-158.73%0.1M1.5M12.10K
2026-06-306.68%0.1M1.5M8.62K
2026-06-157.09%0.1M1.5M9.86K
2026-05-298.34%0.1M1.5M11.10K
2026-05-1534.26%0.1M0.4M15.58K
2026-04-309.44%0.1M1.5M17.85K
2026-04-159.75%0.1M1.5M19.82K
2026-03-31-0.2M-26.22K
2026-03-13-0.2M-27.50K
2026-02-27-0.2M-45.01K
2026-02-13-0.2M-42.80K
2026-01-3011.09%0.2M1.5M43.18K
2026-01-159.70%0.1M1.5M44.14K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-058-KCurrent report2026-10-30SEC
2026-11-033Initial statement of beneficial ownership of securities2026-11-01SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-10-088-KCurrent report2026-10-04SEC
2026-10-018-KCurrent report2026-10-01SEC
2026-09-25ARSAnnual report to security holders. 2026-09-25SEC
2026-09-25DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-25SEC
2026-09-15PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-15SEC
2026-09-158-KCurrent report2026-09-15SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-09-103Initial statement of beneficial ownership of securities2026-08-14SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-09-013Initial statement of beneficial ownership of securities2026-09-01SEC
2026-08-318-KCurrent report2026-08-31SEC
2026-08-284Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-283Initial statement of beneficial ownership of securities2026-08-14SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-243Initial statement of beneficial ownership of securities2026-08-20SEC
2026-08-208-KCurrent report2026-08-14SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-148-KCurrent report2026-08-10SEC
2026-08-10EFFECTEffectiveness filing by commission orderSEC
2026-08-03S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-07-08DNotice of sales of securities on Form D (Regulation D)SEC
2026-07-078-KCurrent report2026-06-30SEC
2026-05-29SDSpecialized Disclosure ReportSEC
2026-05-20S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-2010-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-01SEC
2026-05-203Initial statement of beneficial ownership of securities2026-05-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CITADEL ADVISORS LLC0.64%
RENAISSANCE TECHNOLOGIES LLC0.40%
UBS Group AG0.07%
CITIGROUP INC0.02%
MORGAN STANLEY0.01%
SBI Securities Co., Ltd.0.01%
OSAIC HOLDINGS, INC.0.00%
ROYAL BANK OF CANADA0.00%
NATIONAL BANK OF CANADA /FI/0.00%
Caitong International Asset Management Co., Ltd0.00%

Funds

Fund% owned
Dimensional US Core Equity 1 ETF0.03%
Fidelity Nasdaq Composite Index Fund0.01%
Dimensional U.S. Core Equity 2 ETF0.00%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. LFWD. Cached 15 minutes.

Some panels did not load: insider.